NCT00255346 2025-12-30Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)M.D. Anderson Cancer CenterPhase 2 Completed68 enrolled 13 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled